Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Bimatoprost for Late Day IOP Control
NCT01464424Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2011
- Primary completion
- Jun 2012
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Overall Mean Intraocular Pressure at Week 6. Started Oct 2011; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01464424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464424.